1 / 25

Interpreting the Coagulopathy of Trauma-Shock

Interpreting the Coagulopathy of Trauma-Shock. Faculty. Bryan A. Cotton, MD, MPH The University of Texas Health Science Center Houston, Texas. Richard P. Dutton, MD, MBA University of Maryland School of Medicine R Adams Cowley Shock Trauma Center Baltimore, Maryland.

pahana
Download Presentation

Interpreting the Coagulopathy of Trauma-Shock

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Interpreting the Coagulopathy of Trauma-Shock

  2. Faculty Bryan A. Cotton, MD, MPH The University of Texas Health Science Center Houston, Texas Richard P. Dutton, MD, MBA University of Maryland School of Medicine R Adams Cowley Shock Trauma Center Baltimore, Maryland Martin A. Schreiber, MD, FACS Oregon Health & Science University Portland, Oregon

  3. Mortality After Trauma • Retrospective review of trauma death at level I trauma center (Stewart et al, 2003) • Leading causes of death • CNS, 51% • Shock, 21% • CNS + Shock, 16% Stewart RM, et al. J Trauma . 2003;54:66-71.

  4. Time to Death • Within 12 h of arrival to ED • 50% of trauma patients are dead • Within 48 h of arrival to ED • ≈70% of trauma patients are dead • Early interventions can impact a patient’s life Stewart RM, et al. J Trauma. 2003;54:66-71.

  5. Coagulopathy and Mortality • Retrospective review • N=1867, 24.4% of patients significantly coagulopathic • Coagulopathy defined as: • 1.5 x normal • Mortality • Overall, 19.5% • Noncoagulopathic, 10.9% • Coagulopathic, 46% Brohi K, et al. J Trauma. 2003;54:1127–1130.

  6. Coagulopathy and Mortality Mortality 100 Normal 80 Coagulopathy 60 40 Percent Mortality 20 0 0-14 15-29 30-44 45-59 59-64 Injury Severity Score Adapted from Brohi K, et al. J Trauma. 2003;54:1127–1130.

  7. Acute Coagulopathy of Trauma

  8. Acute Coagulopathy of Trauma 18 17 16 15 14 Prothrombin Time(s) 13 12 11 10 2.1 2.2-4.1 4.2-7.6 7.7 Base Deficit (mEq/L) Adapted with permission from Brohi K, et al. Ann Surg. 2007;245:812-818.

  9. Shock as a Mechanism of Coagulopathy Adapted from Hoffman M. Blood Rev. 2003;17:S1-S5.

  10. Base Deficit and Protein C 80 60 Thrombomodulin (ng/mL) 40 20 2.1 2.2-4.1 4.2-7.6 7.7 Base Deficit (mEq/L) Adapted with permission from Brohi K, et al. Ann Surg. 2007;245:812-818.

  11. Base Deficit and Protein C • Activated protein C is potent anticoagulant • Activates fibrinolysis • In shock state, protein C activation→coagulopathy • Decrease in protein C concentration associated • with marked increase in mortality Brohi K, et al. Ann Surg. 2007;245:812-818.

  12. Protein C Pathway • Thrombomodulin increased • Binds protein C • Produces activated protein C • Inhibits factors V, VIII • Accelerates fibrinolysis

  13. Rateof Heat Transfer Q=mc(T2 - T1) Gentilello LM. In: Maull KI, et al, eds. Advances in Trauma and Critical Care. Vol 9. St Louis, MO: Mosby; 1994:39-79.

  14. Effect of Hypothermia and Dilution 27 25 23 Dilution 21 PT (sec) 19 17 No Dilution 15 13 28 30 32 34 36 38 Temperature (°C) Gubler KD, et al. J Trauma. 1994;36:847-851.

  15. Changes of Plasma Fibrinogen Concentration and Platelet Count • Porcine trauma model • HCI-induced hypothermia and acidosis • pH, 7.1 • Temperature, 32°C • Results: • Increased hypothermia and acidosis significantly • decreased fibrinogen concentration and • PLT counts Martini WZ, et al. J Trauma. 2005;58:1002-1010.

  16. Thrombin Generation 9000 Control 7500 Hypothermic 6000 µg/L) Acidotic 4500 * [TAT] ( * Combined * 3000 * * * 1500 * * * * * 0 * 0 1 2 3 4 5 6 7 Quench Time (min) *P.05, different from normal value at the same quench time point. Posted with permission from Martini WZ, et al. J Trauma. 2005;58:1002–1010. 16

  17. Acute Coagulopathy of Trauma (ACOT) Trauma Hemorrhage Inflammation Resuscitation Shock Other Diseases Acidemia Dilution Fibrinolysis Medications Hypothermia Hypothermia Genetics FactorConsumption Coagulopathy ACoTS Hess JR, et al. J Trauma. 2008;65:748-754.

  18. Conclusions • Coagulopathy following trauma is complex • Severely injured are coagulopathic immediately following injury • Most of what we do makes it worse • Early treatment should focus on stopping bleeding and correcting coagulopathy

  19. Bryan A. Cotton, MD, MPH Associate Professor of Surgery The University of Texas Health Science Center and Center for Translational Injury Research Houston, Texas

  20. Has the way in which you manage the coagulopathy of trauma changed considerably over the course of your career as a surgeon?

  21. Historically • Treatment delayed • Resuscitation emphasized Currently • Arrest bleeding • Correct coagulopathy early • Downplay resuscitation • Adequate organ perfusion • Limit fluids

  22. Richard P. Dutton, MD, MBA Professor of Anesthesiology University of Maryland School of Medicine Attending Anesthesiologist R Adams Cowley Shock Trauma Center Baltimore, Maryland

  23. In the upcoming year, what types of research can we expect to see disseminated in the medical literature concerning resuscitation methods and strategies for managing the coagulopathy of trauma, and what will be the focus of those papers?

  24. Papers on role of recombinant factor VIIa in trauma • Results from prospective, randomized trial expected • ≈600 patients enrolled • Third or fourth largest trauma study ever conducted • Papers on plasma:red cell ratio • Match therapy to patient • Base ratio on needs of particular patient • Prospective and randomized trials

  25. Thank you for participating in this CE activity. To receive credit for this activity, please complete the posttest and evaluation by clicking the “posttest” tab located above and following the instructions. To download the reference list or supplemental slides for this program, please click the appropriate link on the home page of this activity. www.bloodcmecenter.org

More Related